AgomAb Therapeutics NV 20-F for FY2025
AgomAb Therapeutics NV (AGMB)
20-F
2026-04-23
For: 2025-12-31
View Original
Added on
April 23, 2026
About this 20-F
AgomAb Therapeutics NV filed this 20-F on April 23, 2026, covering the fiscal year ended December 31, 2025 (FY2025).
Headline figures
Fiscal year ended December 31, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Net loss
- 62.55M EUR
- compared with a net loss of 46.27M EUR a year earlier
- Diluted EPS
- -143.22 EUR
- compared with -107.09 EUR a year earlier